baber/WOPTO huggingface dataset:
Patent WO-2008005372-A9 (WO)
Title: Ensemble de connecteur électrique à structure d'étanchéité améliorée
Inventor: BOUCHAN CHRISTOPHE
IPC: H01R13/52
Filed: 2007-06-29
Abstract: La présente invention concerne un ensemble de connecteur électrique comportant un boîtier comprenant une pluralité de cavités de réception de borne pour recevoir une pluralité de fils conducteurs de borne. Le boîtier contient un joint principal en matte comprenant une pluralité de trous correspondant aux cavités de réception de borne et un joint secondaire en gel adjacent au joint principal. Une coiffe avec des trous alignés de manière identique avec les cavités de réception de borne est fixée au boîtier, appliquant une force de compression sur les joints principal et secondaire. Les fils conducteurs de borne perforent le second joint, s'étendent à travers les trous dans la coiffe, les joints principal et secondaire et sont réintroduits de manière amovible dans les cavités de réception.
Patent WO-2007143597-A9 (WO)
Title: Composés organiques
Inventor: DALES NATALIE
IPC: A61K31/4245
Filed: 2007-06-04
Abstract: La présente invention concerne des dérivés hétérocycliques modulant l'activité de la stéaroyl-CoA désaturase. La présente invention englobe également des méthodes d'emploi de tels dérivés dans la modulation de l'activité de la stéaroyl-CoA désaturase ainsi que des compositions pharmaceutiques comprenant de tels dérivés.
Patent WO-2008052188-A9 (WO)
Inventor: RUPERTO NETZER ARIAS
IPC: H04W4/029
Filed: 2007-10-26
Abstract: A system and method for locating and tracking one or more devices is disclosed. Location data and status data of the one or more devices is received at a server system through one or more communications networks. The location data includes data from the GPS or A-GPS network. A graphical representation of the location data and status data is then generated by the server system and sent to a client computer executing a location and tracking application for display in a browser window.
Patent WO-2008154281-A9 (WO)
Title: Procédé et appareil d'amélioration d'images
Inventor: STERN MARK C
IPC: G06T5/40
Filed: 2008-06-05
Abstract: L'invention concerne un procédé et un appareil d'amélioration d'images. Une image d'entrée générée par un dispositif d'imagerie, tel qu'une caméra infrarouge de courte longueur d'onde (SWIR), un capteur ou un autre dispositif d'imagerie, est traitée pour produire un histogramme d'entrée représentant la distribution d'intensité de pixel dans l'image d'entrée. Les points de début et de fin d'histogramme sont déterminés et un profil de plateau variable est calculé en fonction du type d'amélioration souhaité. Le profil de plateau pourrait prendre une forme ou une taille souhaitée quelconque et au moins deux régions de plateau pourraient être incluses dans le profil. L'histogramme d'entrée est attaché le long du profil de plateau variable. Un histogramme cumulatif est construit à partir de l'histogramme attaché et est normalisé. L'image d'entrée est ensuite transformée en une image de sortie améliorée en utilisant l'histogramme cumulatif normalisé comme table de conversion.
Patent WO-2011112893-A9 (WO)
Title: Compositions pour améliorer des troubles prolifératifs cellulaires et procédés de préparation et d'utilisation de celles-ci
Inventor: GERWICK WILLIAM H
IPC: A61K9/20
Filed: 2011-03-11
Abstract: Dans différents modes de réalisation, l'invention concerne des composés d'apratoxine F et d'apratoxine G, qui comprennent des stéréoisomères, dérivés et analogues d'apratoxine F et d'apratoxine G, des compositions et des procédés. Dans d'autres modes de réalisation, l'invention concerne des compositions et formulations pharmaceutiques comprenant de l'apratoxine F (composé 6 de la figure 1) et de l'apratoxine G (composé 7 de la figure 1) et leurs stéréoisomères, dérivés et analogues. Dans d'autres modes de réalisation, les compositions et formulations pharmaceutiques de l'invention sont administrées en une quantité suffisante pour traiter, prévenir et/ou améliorer une maladie ou affection qui peut être améliorée en diminuant ou en inhibant la croissance cellulaire, par exemple, une croissance cellulaire pathologique, incontrôlée ou indésirable, par exemple, un cancer ou une métastase, ou une maladie ou affection quelconque (par exemple, une allergie) ou une infection ayant une composante de croissance cellulaire hyperproliférative.
Patent WO-2014070935-A9 (WO)
Title: Dosage quantitatif d'écoulement latéral
Inventor: ANDERBERG JOSEPH
IPC: G01N33/558
Filed: 2013-10-30
Abstract: L'invention concerne des dispositifs, des kits, des instruments et des procédés pour détecter quantitativement de multiples analytes dans un échantillon. De manière plus spécifique, l'invention concerne des dispositifs, des kits, des instruments et des procédés pour détecter quantitativement de multiples analytes avec une précision ciblée ou souhaitée et leurs utilisations.
Patent WO-2019143699-A9 (WO)
Title: Adaptive multivector illumination delivery system
Inventor: ROMO LUIS F
IPC: A23L3/28
Filed: 2019-01-16
Abstract: An ultraviolet emitting system for sanitizing a target volume can include a plurality of adjustably positionable light sources having a collapsed position and the expanded position. The light sources of the plurality of adjustably positionable light sources can be configured to emit ultraviolet light in a substantially homogenous irradiance within the target volume in any position between the collapsed position and the expanded position.
Patent WO-2020077288-A9 (WO)
Inventor: ROMERO JHONATHAN
IPC: B82Y10/00
Filed: 2019-10-11
Abstract: Selon la présente invention, un ordinateur classique quantique hybride (HQC) qui comprend à la fois un composant informatique classique et un composant informatique quantique effectue un apprentissage génératif sur des distributions de données continues. L'ordinateur HQC peut être mis en œuvre à l'aide de composants informatiques quantiques existants et ayant à long terme une profondeur de circuit relativement faible.
Patent WO-2020150598-A9 (WO)
Inventor: WANG ANRAN
IPC: G01S5/22
Filed: 2020-01-17
Abstract: L'invention concerne des systèmes et des procédés pour faciliter la localisation et le suivi de mouvement basés sur l'acoustique en présence de trajets multiples, dans lesquels, en fonctionnement, des signaux acoustiques sont transmis d'un haut-parleur à un réseau de microphones, un processeur couplé au réseau de microphones calcule la distance 1 D entre un microphone et/ou chaque microphone du réseau de microphones et le haut-parleur d'un dispositif d'utilisateur par filtrage en premier lieu de signaux de trajets multiples avec de grandes valeurs de temps d'arrivée par rapport à la valeur de temps d'arrivée du signal de trajet direct, puis extraction de la valeur de phase des signaux à trajets multiples résiduels et du signal de trajet direct, à l'aide des distances 1 D calculées, le processeur peut ensuite calculer l'intersection des distances 1 D pour déterminer l'emplacement 3D du haut-parleur pour permettre une précision inférieure au millimètre d'une distance 1 D entre un microphone d'un réseau de microphones et un haut-parleur d'un dispositif d'utilisateur pour permettre une séparation plus petite entre les microphones du réseau de microphones.
Patent WO-2020210843-A9 (WO)
Inventor: GREEN JORDAN J
IPC: A61K47/69
Filed: 2020-06-12
Abstract: Biodegradable particles for interacting with immune cells to generate an immunosuppressive effect are disclosed. The biodegradable particle comprises a polyester or polyester blend with at least one soluble protein or small molecule encapsulated within the particle and at least two types of protein attached to a surface of the particle or to a coating on the surface thereof, which can be used to induce targeting regulatory T cells (Tregs). The at least two types of protein attached to a surface of the particle or to a coating on the surface thereof include a "Signal 1" protein that binds to an immune cell and a "Signal 2" protein that acts as a co-stimulatory molecule to immune cells. The encapsulated protein can be an interleukin and/or a cytokine. Methods of their use for treating a disease or condition, including an autoimmune disease, are disclosed.
Patent WO-2022046572-A9 (WO)
Inventor: MEHTA SUNIL
IPC: B04B1/20
Filed: 2021-08-21
Abstract: This invention relates to a continuous flow centrifugation device and method of using the device for separation of solids, particles, liquids, or gases from a mixture containing them. The device contains rotating separation chamber in which incoming material continuously enters the chamber via an inlet and the separated materials continuously flow out via two outlets. Solids or heavier materials exit from an outlet tubing, whose opening is placed in a space that is farthest from the center of rotation and has the highest centrifugal force. The liquid / supernatant outlet is placed in the space that is closer to the center of rotation with the lowest centrifugal force. The reference of placement of inlet to solids outlet is in the same direction as the direction of rotation so that the flow of incoming material, directed from inlet to solids outlet, is in the same direction as the direction of rotation. All product contact surfaces can be disposable and diverse separation methods for different applications can be executed in a fully automated or manual manner by a controller that manages different inputs and outputs of system components.
Patent DE-102010026098-A9 (DE)
Title: Ionisch gesteuertes Dreitorbauelement
IPC: G01R29/08
Filed: 2010-07-05
Abstract: Die Erfindung betrifft ein Dreitorbauelement, welches durch die Bewegung von Ionen schaltbar ist. Dieses umfasst eine Source-Elektrode, eine Drain-Elektrode und einen zwischen die Source-Elektrode und die Drain-Elektrode geschalteten Kanal aus einem Material, dessen elektronische Leitfähigkeit durch Zu- und/oder Abführung von Ionen veränderlich ist. Erfindungsgemäß umfasst das Dreitorbauelement ein mit einer Gate-Elektrode kontaktiertes Ionenreservoir, welches derart in Verbindung mit dem Kanal steht, dass es bei Beaufschlagung der Gate-Elektrode mit einem Potential Ionen mit dem Kanal auszutauschen vermag. Es wurde erkannt, dass in der Verteilung der insgesamt in Ionenreservoir und Kanal vorhandenen Ionen auf Ionenreservoir und Kanal Information in dem Dreitorbauelement gespeichert werden kann. Die Verteilung der Ionen auf den Kanal und auf das Ionenreservoir ändert sich dann und nur dann, wenn ein entsprechendes treibendes Potential an der Gate-Elektrode angelegt wird. Im Gegensatz zu RRAMs existiert daher kein „time-voltage dilemma”.
Patent DE-102013222369-A9 (DE)
Title: Ein Matrix-Phasendetektor
Inventor: DALLY WILLIAM J
IPC: H03K5/00
Filed: 2013-11-04
Abstract: Ein Verfahren und ein System sind für Taktphasendetektion bereitgestellt. Ein erster Satz von verzögerten Versionen eines ersten Taktsignals wird erzeugt und ein zweiter Satz von verzögerten Versionen eines zweiten Taktsignals wird erzeugt. Der zweite Satz von verzögerten Versionen des zweiten Taktsignals wird unter Verwendung des ersten Satzes von verzögerten Versionen des ersten Taktsignals gesampelt, um ein Array von Taktsamples in einer Domain zu produzieren, die dem ersten Taktsignal entspricht. Zumindest eine Flankenindikation wird innerhalb des Arrays von Taktsamples lokalisiert.
Patent CS-261708-B1 (CS)
Inventor: LIPUS PAVEL ING
IPC: A61L2/26
Filed: 1987-01-05
Abstract: Účelem řešení je dokonale utěsnění
dveří sterilizačního přístroje gři současné
konstrukční jednoduchosti, přičemž
qbsluha přístroje je snadná a^rychlá. Účelu je dosaženo tím, že plášt pracovní
komory je z čelní strany opatřen opěrným
elementem, na který doléhá těsnění uspořádané
po obvodu pláště pracovní komory,
na které doléhá závěrná deska. Těsné spoje
pláště pracovní komory a závěrné desky
s těsněním jsou vytvořeny rozdílem
tlaku v pracovní komoře vůči tlaku atmosférickému.
Patent IE-35958-B1 (IE)
Title: A pipe connection
Inventor: OOSTENBRINK A A
IPC: F16L41/02
Filed: 1972-01-06
Abstract: Pipe connection comprising a pipe and a branch pipe being connected by means of a sleeve having an inner helical profile corresponding to the profile of the branch pipe and a groove for receiving the edge of an opening in the pipe.
[US3831985A]
Patent CS-268232-B1 (CS)
Title: Connection for turn-off time end determination with switch formed at least by one bipolar transistor
Inventor: KOKES ANTONIN RNDR CSC
IPC: H03K17/18
Filed: 1988-01-15
Abstract: Circuit arrangement comprising at least one bipolar transistor (2) controlled by a current source, between the base and the emitter of which transistor (2) the input of a threshold voltage discriminator (3) provided with an output for indication of the disconnection time is connected.
Patent CS-233214-B1 (CS)
Inventor: LEDERLEITNER MILAN
IPC: C11D7/60
Filed: 1983-01-31
Abstract: Emulzný roztok na ošetrovanie ofsetových
tlačových fořtem v tlačovom stroji obsahuje
polyvinýlesterovú disperziu ako zložku zabezpečujúcu
ochranu hydrofilných častí
ofsetovej platné. Leptací účinok emulzného
roztoku zabezpečuje přítomnost fluoridu
alkalického kovu. Ako hydrofilizačné činidlo
sa používá kyselina fosforečná a zložkou
zabezpečujúcou odstránenie tlačovej farby
je terpentín. Rozpúštanie tlačovej farby
podporuje přítomnost! trietylénglykolu. Na
zlepšenie zmóčavosti sa přidává tenzid zo
skupiny neiónových tegzidov typu oxietylovaných
amínov so stupnom oxidácie 7 až 20.
Hlavné výhody emulzného roztoku spočívajú
v tom, že dokonale čistí hydrofilné miesta
od případného nánosu tlačovej farby, zároveffnydrofilizuje
ňetlačiace miesta tlačovej
formy a rozpúšťa tlačovú farbu na
tlačiacich prvkoch, zabraňuje oleofilizácii
hydrofilného povrchu odstraňovanou tlačovou
farbou.
Patent DK-172393-B1 (DK)
Inventor: HOLMSKOV INGE MARIE
IPC: A61L31/00
Filed: 1992-06-10
Granted: 1998-05-18
Abstract: A method of producing an article with a coating having friction-reducing properties in wet condition, said coating comprising a binder (a), a hydrophilic polymer (b), as well as an osmolality-increasing compound (c), where the osmolality-increasing compound (c) is applied in a condition different from a water-based dissolved condition, preferably in a non-dissolved, solid condition, as well as an article with a coating having friction-reducing properties in wet condition, said coating comprising a binder (a), a hydrophilic polymer (b), and an osmolality-increasing compound (c) in form of particles of a size of maximum 50  mu m. The method can be performed in a simple and fast manner without involving a time-delaying evaporation of water, and the article is remarkable for the osmolality-increasing compound being uniformly dispersed in the coating.
Patent IE-47833-B1 (IE)
Title: Process for solubilizing an insoluble drug and an aqueous solution prepared by this process
IPC: A61K47/48
Filed: 1979-02-12
Abstract: A soluble complex of an insoluble drug, exemplified by Rafoxanide, is formed with polyvinylpyrrolidone and water. The complex is formed by combining the insoluble drug and polyvinylpyrrolidone in a suitable water-miscible organic solvent, preferably acetone or glycerolformal, and water. The complex is formed in situ. The solvent may be removed, if desired, and the complex remains in aqueous solution. The aqueous solution is then suitable for injection and may be used to treat fasciola or liver fluke infections.
Patent IE-66471-B1 (IE)
Title: Colorimetric method for continuous control of impurities on hydrate of alumina
Inventor: DABLAINVILLE RAYMOND
IPC: G01N21/85
Filed: 1991-02-25
Abstract: Continuous monitoring of the impurity content in a product travelling past in bulk and with a nonuniform thickness on a conveyor belt. The monitored impurity giving a colour reaction with a suitable reagent. 
<??>The invention consists of the combination of three means: 
 
  - a means for levelling the upper surface of the product on the belt at least in a certain region, 
  - a means for spraying the reagent on the surface of the product which is thus levelled, in order to develop the colour by reaction with the impurity 
  - a means for colorimetric determination of the intensity of the colour obtained with the aid of the reagent. 
 
<??>The invention applies in particular to the monitoring of the residual sodium hydroxide content in alumina trihydrate obtained in the Bayer process before it is calcined. 
<IMAGE>
Patent IE-35269-B1 (IE)
Title: Controlled suds detergent composition
IPC: C11D3/37
Filed: 1971-05-20
Abstract: 1304803 Low foam detergent composition PROCTER & GAMBLE CO 20 May 1971 [20 May 1970] 16015/71 Heading C5D A detergent composition comprises (a) 2- 30% of a non-cationic surface active agent, (b) 0À05-5% of a suds controlling agent selected from finely divided silenated silica, silicones and finely divided by dropholic polymers of ethylene, fluoroethylene, butylene, isobutylene and styrene and (c) 0À5-8% of either (i) a homopolymer of methyl vinyl either, ethyl vinyl ether, vinyl acetate, vinyl propionate or vinyl pyrrolidone or a copolymer of 2 or more of these monomers having a molecular weight of 5,000- 50,000 or (ii) a copolymer of maleric anhydride and ethylene, styrene or a C 1-4 alkyl vinyl ether having a molecular weight of 10,000-300,000 or a water-soluble alkali metal salt thereof or (iii) a polyethylene glycol of molecular weight 1,000- 50,000. The composition may also include a builder and a peroxy compound. Ingredients specified include: surface active agents sodium C 11À8 alkyl benzene sulphonate, tallow fatty alcohol Sulphate (sodium Salt), Sodium coconut oil fatty alcohol sulphate, 3-(C 14À 8 alkyl dimethyl ammonio)-propane-1-sulphonate, 3-(C 14À8 alkyl dimethyl ammonio)-2-hydroxypropane-1- sulphonate, 3 - (N,N-dimethyl - N - tetradecylammonio) - propane-1-phosphate, tallow alcohol ethylene oxide adduct, stearyl dimethylamine oxide, laruyl-dhosphine oxide; suds controlling agents: silanated silica, polydimethyl siloxane, polymethyl pheuyl siloxane, component (c): sodinm salt of vinyl acetate-vinyl pyrrolidone copolymer, sodium salt of maleic anhydride-styrene copolymer, sodium salt of maleio anhydridevinyl methyl ether copolymer, sodium salt of maleic anhydride-vinyl butyl ether copolymer, builders: trisodium ethylene-1-hydroxy -1,1- diphosphonate, sodium tripolyphosphate, chlorinated trisodium phosphate, sodium chloride, sodium silicate, sodium sulphate, trisodium nitrilo triacetate, sodium ethylene diamine tetra-acetate, peroxy-compounds: sodium perborate, other ingredients: hydrogenated fatty acids, carboxymethyl cellulose, sodium toluene sulphonate, monoethanolamine, silica, amylase and protease enzymes, brighteners, dyes, perfumes and water.
[GB1304803A]
Patent IE-39211-B1 (IE)
Title: Diuretic and antihypertensive medicines comprising pyrazololone derivatives
IPC: C07D231/20
Filed: 1974-04-17
Abstract: Pharmaceutical compositions useful for effecting diuresis and saluresis and for treating hypertension in humans and animals are produced by combining a pyrazol-5-one of the formula: <IMAGE> or a pharmaceutically acceptable nontoxic salt thereof wherein R is hydrogen, lower alkyl or amino; X is methylene, ethylene, methylene wherein 1 hydrogen atom is substituted by lower alkyl, or ethylene wherein 1 hydrogen atom is substituted by lower alkyl or 1 hydrogen atom on each of the two carbon atoms is substituted by lower alkyl; Y is a direct bond, oxygen or sulphur, provided that when X is methylene wherein 1 hydrogen atom is substituted by alkyl of 1 to 4 carbon atoms, Y is a direct bond; Z is aryl of 6 to 10 carbon atoms unsubstituted or substituted by: (a) 1 or 2 of the same or different substituents selected from the group consisting of halogen, trifluoromethyl, alkyl of 1 to 4 carbon atoms, alkenyl of 2 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, and alkenoxy of 2 to 4 carbon atoms; (b) lower alkylamino, dilower alkylamino, trifluoromethoxy, nitro, cyano, carbamoyl, lower alkylcarbamoyl, dilower alkylcarbamoyl, sulphamyl,lower alkylsulphamyl, dilower alkylsulphamyl, -SOn-lower alkyl wherein n is 0, 1 or 2, or said dialkylamino, carbamoyl, alkylcarbamoyl, dialklycarbamoyl, sulphamyl, alkylsulphamyl, or dialkylsulphamyl, the nitrogen atom of which is a member of a 5-, 6- or 7-membered ring or said ring which additionally contains an oxygen atom; (c) lower alkylamino, dilower alkylamino, trifluoromethoxy, nitro, cyano, carbamoyl, lower alkylcarbamoyl, dilower alkylcarbamoyl, sulphamyl, lower alkylsulphamyl, dilower alkylsulphamyl, or -SOn-lower alkyl wherein n is 0, 1 or 2, and 1 or 2 substituents selected from the group consisting of alkyl of 1 to 4 carbon atoms, alkenyl of 2 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkenoxy of 2 to 4 carbon atoms, halogen and trifluoromethyl; or (d) a fused, saturated or unsaturated 5-, 6- or 7-membered ring or said ring additionally containing 1 or 2 oxygen or sulphur atoms, in combination with a pharmaceutically acceptable nontoxic inert diluent or carrier. The compositions are preferably administered orally or parenterally and in the latter case, sterile or isotonic aqueous solutions are preferred.
[US4288446A]
Patent IE-39366-B1 (IE)
Title: Semi-moist animal food
IPC: A23K3/00
Filed: 1974-04-17
Abstract: 1467432 Semi-moist animal feed MARS Ltd 19 April 1974 [25 April 1973] 19703/73 Heading A2B A semi moist animal feed product comprises edible proteinaceous material stabilized against bacterial growth by the inclusion of a low molecular weight (as defined) polypeptide material, the product having a moisture content of 15-45% by wt. a water activity of less than 0.95 and containing 5-30% by wt. of the polypeptide. Preferably the product has a pH in the range 3.5-7 and a water activity of 0.75-0.95. Specified polypeptide materials include fish solubles and fish and meat autolysates. The product, which may also include a heat coagulated binder and other fat, nutritional and cereal filler additives is made by mixing the ingredients and forming into the desired shapes and then if necessary, (e.g. to coagulate the binder) heating.
[GB1467432A]
Patent IE-32264-B1 (IE)
Title: Pharmaceutical compositions
IPC: C07D223/26
Filed: 1968-08-09
Abstract: 1,176,194. Pharmaceutical preparations containing imipramines. GEIGY (U.K.) Ltd. 9 Aug., 1968 [12 Aug., 1967], No. 37136/67. Heading A5B. [Also in Division C3] A pharmaceutical preparation (providing immediate and rapid release of the therapeutic agent for oral administration) comprises a suspension or dispersion, in a carrier liquid which is substantially free of ions or ionisable material, of a solid compound formed from imipramine, chlorimipramine, 10-keto-imipramine, desimipramine or opipramol base and a cation-exchange resin in the form of a methacrylate polymer containing carboxyl groups and having a degree of cross-linkage from 1 to 10%. The base is combined with the resin by agitating the resin with a solution of the base, e.g. in an acetone/water or isopropanol/water mixture, in the proportion of base to resin from 10 to 50% on a dry weight to weight basis. The resin may be a polymethacrylic acid or a copolymer of methacrylic acid and divinyl benzene, preferably having a particle size in the range of from 1 to 150 microns. The base may be used in the form of a pharmaceutical grade free base or it may be set free from the corresponding salt, preferably the hydrochloride, by solvent extraction after making alkaline, or by passing through an anion-exchange resin column, e.g. a polystyrene type polymer containing quaternary ammonium groups and cross-linked with divinyl benzene. The carrier liquid medium may comprise water and may also contain one or more sweeteners, flavours, colloid thickening agents, colours and preservatives.
[GB1176194A]